Chan Zuckerberg Biohub

The Chan Zuckerberg Biohub is launching a fourth round of rare disease grants, having already committed over $150 million across four funding cycles. The organization is also expanding its AI-driven drug repurposing initiatives in collaboration with Every Cure.

The Chan Zuckerberg Biohub is launching a new funding initiative to accelerate rare-disease treatments by supporting patient-led organizations and scientists. The effort aims to build research networks, collect data, establish registries, and foster collaboration between patients, physicians, and researchers to overcome challenges in developing therapies for overlooked conditions.